;

Search Results:

Showing of 50

CLINICAL TRIAL17933

A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Cancer Type: Gynecological Tumor

View Trial Details

CLINICAL TRIAL18190

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Efficacy and Safety of Farletuzumab (MORAb-003) in Combination with Carboplatin plus Paclitaxel or Carboplatin plus Peglyated Liposomal Doxorubicin (PLD) in Subjects with Low CA125 Platinum-Sensitive Ovarian Cancer

Cancer Type: Gynecological Tumor

View Trial Details

CLINICAL TRIAL18345

A Phase 1 Trial of MK-3475 Plus Ziv-Aflibercept in Patients with Advanced Solid Tumors

Cancer Type: Genitourinary

View Trial Details

CLINICAL TRIAL18682

Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer: Prospective Study of Pharmacokinetics Patterns and Underlying Biology.

Cancer Type: Gynecological Tumor

View Trial Details

CLINICAL TRIAL18855

Multicenter, Open-label, Phase 1, Dose-escalation,Cohort-expansion, First-in-Human Study of KHK2455 Administered as Monotherapy and in Combination with Mogamulizumab (KW-0761) in Adult Subjects with Locally Advanced or Metastatic Solid Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18119

A Phase 1b Study Evaluating the Safety, Tolerability and Immunogenicity of CMB305 (Sequentially Administered LV305 and G305) in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1

Cancer Type: Sarcoma

View Trial Details

CLINICAL TRIAL18207

Phase 2 Trial of Dose Dense (Weekly) Paclitaxel with Pembrolizumab (MK-3475) in Platinum Resistant Recurrent Ovarian Cancer

Cancer Type: Gynecological Tumor

View Trial Details

CLINICAL TRIAL18495

Caregiver Relationship Quality and Communication in Advanced Cancer Care

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18837

An Open-Label Study of Rovalpituzumab Tesirine in Subjects with Delta-Like Protein 3-Expressing Advanced Solid Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18825

A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1522 in Patients with Advanced Breast Cancer and Other Advanced Tumors Expressing HER2

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18826

A Phase 1 Study of ALKS 4230 in Subjects with Advanced Solid Tumors

Cancer Type: Genitourinary

View Trial Details

CLINICAL TRIAL19112

DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors

Cancer Type: Multiple

View Trial Details